However, quickly following the development of the field-deployable test, it was found that some persons cleared of parasitemia were still capable of testing positive to HRP2 up to a month following successful treatment, leading to reduced confidence in the test as a genuine or reliable diagnostic [10–13]. This evidence concerns the gene HDGFL2 and parasitic infectious disease.